Cel-Sci
CVM
#9944
Rank
NZ$63.67 M
Marketcap
NZ$7.97
Share price
-5.91%
Change (1 day)
-78.56%
Change (1 year)

Market capitalization of Cel-Sci (CVM)

Market cap: NZ$63.67 Million

As of December 2025 Cel-Sci has a market cap of NZ$63.67 Million. This makes Cel-Sci the world's 9944th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Cel-Sci from 1996 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$63.67 M-6.21%
2024NZ$67.89 M-68.42%
2023NZ$0.21 B32.96%
2022NZ$0.16 B-64.03%
2021NZ$0.44 B-30.03%
2020NZ$0.64 B31.37%
2019NZ$0.48 B310.5%
2018NZ$0.11 B239.01%
2017NZ$35.14 M91.94%
2016NZ$18.3 M-73.98%
2015NZ$70.35 M3.71%
2014NZ$67.83 M68.62%
2013NZ$40.22 M-60.32%
2012NZ$0.10 B18.73%
2011NZ$85.39 M-61.05%
2010NZ$0.21 B-13.04%
2009NZ$0.25 B314.93%
2008NZ$60.75 M-21.18%
2007NZ$77.08 M16.51%
2006NZ$66.16 M21.26%
2005NZ$54.56 M-10.22%
2004NZ$60.76 M-42.78%
2003NZ$0.10 B494.53%
2002NZ$17.86 M-66.81%
2001NZ$53.81 M-22.36%
2000NZ$69.31 M-13.17%
1999NZ$79.83 M87.87%
1998NZ$42.49 M-66.97%
1997NZ$0.12 B150.96%
1996NZ$51.25 M

End of Day market cap according to different sources

On Dec 21st, 2025 the market cap of Cel-Sci was reported to be:

NZ$58.26 Million
by Nasdaq info icon info icon
NZ$67.67 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Curis
CRIS
NZ$24.52 M-61.49%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
NZ$2.76 B 4,239.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$307.51 B 482,835.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
NZ$1.96 B 2,984.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$61.42 B 96,363.02%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Johnson & Johnson
JNJ
NZ$860.24 B 1,350,840.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$1.17 B 1,740.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
NZ$17.05 M-73.22%๐Ÿ‡บ๐Ÿ‡ธ USA